Expression of hormone receptors, Bcl-2, Cox-2 and Ki67 in benign endometrial polyps and their association with obesity

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2335-2341

  Pinheiro, Anderson ^a   Antunes Jr , Armando ^a   Andrade, Liliana ^a   De Brot, Louise ^b   Pinto Neto, Aarão Mendes ^a   Costa Paiva, Lúcia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Bcl 2; Cox 2; Endometrial polyps; Estrogen receptor; Ki67; Obesity; Progesterone receptor

Indexed keywords

CYCLOOXYGENASE 2; ESTROGEN RECEPTOR; HORMONE RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN BCL 2;

ADULT; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOMETRIUM POLYP; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; TISSUE MICROARRAY; COMPLICATION; ENDOMETRIUM TUMOR; METABOLISM; OBESITY; POLYP;

BODY MASS INDEX; CROSS-SECTIONAL STUDIES; CYCLOOXYGENASE 2; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; OBESITY; POLYPS; PREMENOPAUSE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84899668955     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2125     Document Type: Article

References (31)

1. World Health Organization (WHO): Obesity and overweight. http://www.who.int/mediacentre/factsheets. Accessed 22 May, 2012.
2. Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein F, Heiman JR, et al: Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 15: 584-602, 2008.
3. Gouveia DA, Bahamondes L, Aldrighi JM, Tamanaha S, Ribeiro AL and Aoki T: Prevalence of endometrial injury in asymptomatic obese women. Rev Assoc Med Bras 53: 344-348, 2007 (In Portuguese).
4. Dreisler E, Stampe Sorensen S, Ibsen PH and Lose G: Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol 33: 102-108, 2009.
5. Baiocchi G, Manci N, Pazzaglia M, Giannone L, Burnelli L, Giannone E, et al: Malignancy in endometrial polyps: A 12-year experience. Am J Obstet Gynecol 201: 462.e1-4, 2009.
6. Lieng M, Istre O, Sandvik L and Qvigstad E: Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: cross-sectional study. J Minim Invasive Gynecol 16: 465-471, 2009.
7. Sant'Ana de Almeida EC, Nogueira AA, Candido dos Reis FJ, Zambelli Ramalho LN and Zucoloto S: Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. Maturitas 49: 229-233, 2004. (Pubitemid 39370790)
8. Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gerhenson DM and Lu KH: Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106: 2376-2381, 2006. (Pubitemid 43787661)
9. Oguz S, Sargin A, Kelekci S, Aytan H, Tapisiz OL and Mollamahmutoglu L: The role of hormone replacement therapy in endometrial polyp formation. Maturitas 50: 231-236, 2005. (Pubitemid 40269906)
10. Onalan R, Onalan G, Tonguc E, Ozdener T, Dogan M and Mollamahmutoglu L: Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization. Fertil Steril 91: 1056-1060, 2009.
11. Belisário MS, Vassallo J, Andrade L, Alvarenga M, Pinto GA and Monteiro IM: The expression of the hormone receptors in the endometrium and endometrial polyps in postmenopausal women and its relationship to body mass index. Maturitas 53: 114-118, 2006. (Pubitemid 41736067)
12. McGurgan P, Taylor LJ, Duffy SR and O'Donovan PJ: An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to HRT. Maturitas 53: 454-461, 2006.
13. Risberg B, Karlsson K, Abeler V, Lagrelius A, Davidson B and Karlsson MG: Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenic implications. Int J Gynecol Pathol 21: 155-160, 2002. (Pubitemid 34260636)
14. Tokyol C, Aktepe F, Dilek FH, Sahin O and Arioz DT: Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis. Int J Gynecol Pathol 28: 148-156, 2009.
15. Maia H Jr, Pimentel K, Silva TM, Freitas LA, Zausner B, Athayde C, et al: Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle. Gynecol Endocrinol 22: 219-224, 2006.
16. Gao J, Tian J, Lv Y, Shi F, Kong F, Shi H, et al: Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci 100: 389-395, 2009.
17. Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N, Papadias K, Kondi-Pafiti A and Creatsas G: Clinical parameters linked with malignancy in endometrial polyps. Climacteric 12: 454-458, 2009.
18. Costa-Paiva L, Godoy CE Jr, Antunes A Jr, Caseiro JD, Arthuso M and Pinto-Neto AM: Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics. Menopause 18: 1278-1282, 2011.
19. Harvey JM, Clark GM, Osborne CK and Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17: 1474-1481, 1999. (Pubitemid 29220854)
20. Stuart-Harris R, Caldas C, Pinder SE and Pharoah P: Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast 17: 323-334, 2008.
21. Dowsett M, Nielsen TO, A'Hern R, Bartlett J, Coombes RC, Cuzick J, et al: Assessment of Ki67 in breast cancer: recommendation from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst 103: 1656-1664, 2011.
22. Lopes RG, Baracat EC, de Albuquerque Neto LC, Ramos JF, Yatabe S, Depesr DB, et al: Analysis of estrogen- and progesterone- receptor expression in endometrial polyps. J Minim Invasive Gynecol 14: 300-303, 2007. (Pubitemid 46660789)
23. Gul A, Ugur M, Iskender C, Zulfikaroglu E and Ozaksit G: Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters. Arch Gynecol Obstet 281: 479-483, 2010.
24. Villavicencio A, Aguilar G, Argüello G, Dünner C, Gabler F, Soto E, et al: The effect of overweight and obesity on proliferation and activation of AKT and ERK in human endometria. Gynecol Oncol 117: 96-102, 2010.
25. Inceboz US, Nese N, Uyar Y, Ozcakir HT, Kurtul O, Baytur YB, et al: Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps. Gynecol Obstet Invest 61: 24-28, 2006. (Pubitemid 43087547)
26. McGurgan P, Taylor LJ, Duffy SR and O'Donovan PJ: Are endometrial polyps from pre-menopausal women similar to postmenopausal women? An immunohistochemical comparison of endometrial polyps from pre- and post-menopausal women. Maturitas 54: 277-284, 2006. (Pubitemid 43728772)
27. Taylor LJ, Jackson TL, Reid JG and Duffy SR: The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. BJOG 110: 794-798, 2003. (Pubitemid 37159263)
28. Amalinei C, Cianga C, Balan R, Cianga P, et al: Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium. Ann Anat 193: 43-55, 2011.
29. Erdemoglu E, Güney M, Karahan N and Mungan T: Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps. Maturitas 59: 268-274, 2008.
30. Nishimura S, Manabe I and Nagai R: Adipose tissue in obesity and metabolic syndrome. Discov Med 8: 55-60, 2009.
31. Byers T and Sedjo RL: Does intentional weight loss reduce cancer risk? Diabetes Obes Metab 13: 1063-1072, 2011.